Welcome to the CV Technologies HUB on AGORACOM
COLD-fX remains the #1 selling cold and flu remedy in Canada
CV Technologies Profile
CORPORATE PROFILE:
CV Technologies Inc. is a natural health and life sciences company based in Edmonton, Alberta. Since inception in 1992 we have been committed to preventative medicine and becoming a world leader in discovering and developing evidence-based natural health products.
Investment Highlights
COLD-fX® approved by Health Canada to fight colds and flu by boosting the immune system | |
COLD-fX remains the #1 selling cold and flu remedy in Canada* | |
Efficient R&D and strong product pipeline | |
Experienced and disciplined management | |
High margins | |
Domestic and international growth opportunities | |
Early in growth curve |
Key Facts
CVQ trades on the Toronto Stock Exchange | |||||||||||||||
Spun off from Faculty of Medicine, University of Alberta in 1992 | |||||||||||||||
Life sciences company focused on evidence-based preventative health care products | |||||||||||||||
Breakthrough patented discovery and standardization technology utilized to develop ChemBioPrint™ products | |||||||||||||||
Clinical trials: science and evidence-based, double-blind, placebo-controlled, randomized | |||||||||||||||
Lead commercialized products: COLD-fX®, REMEMBER-fX® and CELL-fX® | |||||||||||||||
U.S. FDA clearance to sell COLD-fX as an immune enhancing, New Dietary Ingredient (NDI) in the U.S. | |||||||||||||||
Health Canada product license to sell COLD-fX under a therapeutic claim to reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system Vision and Strategy
Lead Commercial Products:
|
Last changed at 03-Sep-2011 12:07AM by AGORACOM-GT